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Molecules composed of -1,4-linked N-acetylglucosamine (GlcNAc) and deacetylated glucosamine units play
key roles as surface constituents of the human pathogenic fungus Cryptococcus neoformans. GlcNAc is the
monomeric unit of chitin and chitooligomers, which participate in the connection of capsular polysaccharides
to the cryptococcal cell wall. In the present study, we evaluated the role of GlcNAc-containing structures in the
assembly of the cryptococcal capsule. The in vivo expression of chitooligomers in C. neoformans varied
depending on the infected tissue, as inferred from the differential reactivity of yeast forms to the wheat germ
agglutinin (WGA) in infected brain and lungs of rats. Chromatographic and dynamic light-scattering analyses
demonstrated that glucuronoxylomannan (GXM), the major cryptococcal capsular component, interacts with
chitin and chitooligomers. When added to C. neoformans cultures, chitooligomers formed soluble complexes
with GXM and interfered in capsular assembly, as manifested by aberrant capsules with defective connections
with the cell wall and no reactivity with a monoclonal antibody to GXM. Cultivation of C. neoformans in the
presence of an inhibitor of glucosamine 6-phosphate synthase resulted in altered expression of cell wall chitin.
These cells formed capsules that were loosely connected to the cryptococcal wall and contained fibers with
decreased diameters and altered monosaccharide composition. These results contribute to our understanding
of the role played by chitin and chitooligosaccharides on the cryptococcal capsular structure, broadening the
functional activities attributed to GlcNAc-containing structures in this biological system.
Cryptococcus neoformans is the etiologic agent of cryptococ-
cosis, a disease still characterized by high morbidity and mor-
tality despite antifungal therapy (3). Pathogenic species be-
longing to the Cryptococcus genus also include Cryptococcus
gattii, which causes disease mostly in immunocompetent indi-
viduals (24). A unique characteristic of Cryptococcus species is
the presence of a polysaccharide capsule, which is essential for
virulence (7–9, 19, 25, 33).
C. neoformans has a complex cell surface. The thick fungal
cell wall is composed of polysaccharides (29), pigments (11),
lipids (35), and proteins (36). External to the cryptococcal cell
wall, capsular polysaccharides form a capsule (19). Seemingly,
the assembly of the surface envelope of C. neoformans requires
the interaction of cell wall components with capsular elements.
Some of the cryptococcal cell wall-capsule connectors have
been identified, including the structural polysaccharide -1,3-
glucan and chitooligomers (29, 30, 32).
Chitin-like molecules in fungi are polymerized by chitin syn-
thases, which use cytoplasmic pools of UDP-GlcNAc (N-
acetylglucosamine) to form -1,4-linked oligosaccharides and
large polymers. In C. neoformans, the final cellular site of chitin
accumulation is the cell wall. The polysaccharide is also used
for chitosan synthesis through enzymatic deacetylation (1).
Eight putative cryptococcal chitin synthase genes and three
regulator proteins have been identified (2). The chitin synthase
Chs3 and regulator Csr2 may form a complex with chitin
deacetylases for conversion of chitin to chitosan (1). Key early
events in the synthesis of chitin/chitosan require the activity of
glucosamine 6-phosphate synthase, which promotes the glu-
tamine-dependent amination of fructose 6-phosphate to form
glucosamine 6-phosphate, a substrate used for UDP-GlcNAc
synthesis (23).
In a previous study, we demonstrated that -1,4-linked
GlcNAc oligomers, which are specifically recognized by the wheat
germ agglutinin (WGA), form bridge-like connections between
the cell wall and the capsule of C. neoformans (32). In fact, other
reports indicate that molecules composed of GlcNAc or its
deacetylated derivative play key roles in C. neoformans structural
biology. For example, mutations in the genes responsible for the
expression of chitin synthase 3 or of the biosynthetic regulator
Csr2p caused the loss of the ability to retain the virulence-
related pigment melanin in the cell wall (1, 2). These cells were
also defective in the synthesis of chitosan, which has also been
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demonstrated to regulate the retention of cell wall melanin (1).
Treatment of C. neoformans acapsular mutants with chitinase
affected the incorporation of capsular components into the cell
wall (32). Considering that melanin and capsular components
are crucial for virulence, these results strongly suggest that
GlcNAc-derived molecules are key components of the C. neo-
formans cell surface. The expression of GlcNAc-containing
molecules is likely to be modulated during infection since chiti-
nase expression by host cells is induced during lung cryptococ-
cosis (37).
In this study, we used -1,4-linked GlcNAc oligomers and an
inhibitor of UDP-GlcNAc synthesis to evaluate the role played
by GlcNAc-containing molecules in the surface architecture of
C. neoformans. The results point to a direct relationship be-
tween the expression of GlcNAc-containing molecules and
capsular assembly, indicating that chitin and chitooligomers
are required for capsule organization in C. neoformans.
MATERIALS AND METHODS
Inhibitors of capsule assembly. To study capsule assembly in C. neoformans,
two different reagents related to the metabolism of GlcNAc-containing mole-
cules were used. Chitin and chitooligomers were recently described as crypto-
coccal components linking the cell wall to the capsule (32). Chitin is not water
soluble, but chitooligomers of two to six -1,4-linked GlcNAc units are soluble in
aqueous solvents. In our study, different chitooligomers were used for interac-
tions with capsular components. The -1,4-GlcNAc trimeric N, N,N-triace-
tylchitotriose (GlcNAc)3 was the prototype in capsular assembly assays. Chitin-
derived oligosaccharides were obtained from Dextra Laboratories.
Glucosamine 6-phosphate, the first aminosugar used for the synthesis of UDP-
GlcNAc, is synthesized by amination of fructose 6-phosphate with glutamine by
glucosamine 6-phosphate synthase (23). Synthetic dipeptides containing the glu-
tamine analog N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP)
were previously described to inhibit this enzyme in Candida albicans (21, 22).
One of these FMDP dipeptides, L-norvalyl-FMDP (Nva-FMDP), was shown to
inhibit enzyme activity and to mediate effective antifungal effects in a mouse model
of systemic candidiasis (21, 22). A protein search in the C. neoformans data-
base (http://www.broad.mit.edu/annotation/genome/cryptococcus_neoformans.2
/Blast.html) revealed the existence of two hypothetical proteins with significant
homology to the C. albicans protein (loci CNAG_01164.1 and CNAG_02853.1).
Therefore, we hypothesized that Nva-FMDP might also inhibit GlcNAc synthesis
in C. neoformans and monitored its action by chitin staining in fluorescence-
based assays.
Fungal cells. The C. neoformans strain used in most experiments was the
standard serotype A isolate H99. The serotype D isolate 24067 was used for
animal infections. Yeast cells were inoculated into 100-ml Erlenmeyer flasks
containing 50 ml of minimal medium composed of glucose (15 mM), MgSO4 (10
mM), KH2PO4 (29.4 mM), glycine (13 mM), and thiamine-HCl (3 M; pH 5.5).
Fungal cells were cultivated for 2 days at 30°C, with shaking. Yeast cells were
obtained by centrifugation, washed in phosphate-buffered saline (PBS), and
counted in a Neubauer chamber. For morphological analyses, cryptococcal yeasts
(104 cells) were suspended in 50 l of minimal medium. Using U-shaped 96-well
plates, this suspension was mixed with 50 l of the same medium containing
chitotriose (GlcNAc)3 or Nva-FMDP in concentrations varying from 0 to 100
g/ml. After 48 h of cultivation at room temperature, aliquots of the cultures
were taken for microscopic analyses.
Fluorescence microscopy. The staining reagents used in fluorescence micros-
copy included the lectin WGA, with known affinity for -1,4-linked GlcNAc
oligomers, calcofluor white, which has been extensively used to stain chitin in
fungal cells due to its ability to recognize the (GlcNAc-1,4-GlcNAc)n polymer,
and the monoclonal antibody (MAb) 18B7, a mouse immunoglobulin G1 (IgG1)
with high affinity for glucuronoxylomannan (GXM) of different cryptococcal
serotypes (5). Yeast cells (106) were suspended in 4% paraformaldehyde caco-
dylate buffer (0.1 M; pH 7.2) and incubated for 30 min at room temperature.
Fixed yeast cells were washed twice in PBS and incubated in 1% bovine serum
albumin in PBS (PBS-BSA) for 1 h. The cells were then suspended in 100 l of
a 5 g/ml solution of the Alexa Fluor 594 conjugate of WGA (Molecular Probes)
and incubated for 30 min at 37°C. After the cells were washed in PBS, they were
incubated with 25 M calcofluor white (Invitrogen) under the same conditions.
The cells were washed again and incubated for 1 h in the presence of MAb 18B7
(1 g/ml). After the cells were washed in PBS, they were finally incubated with
a fluorescein isothiocyanate-labeled goat anti-mouse IgG (Fc specific) antibody
(Sigma). For a negative control we used an isotype-matched irrelevant IgG at
the same concentrations used for MAb 18B7. To eliminate the possibility that the
fluorescence pattern was derived from a specific sequential use of reagents, the
order of the reagents was changed, and the results were the same (data not
shown). Cell suspensions were mounted over glass slides as described above and
analyzed under an Axioplan 2 (Zeiss, Germany) fluorescence microscope. Im-
ages were acquired using a Color View SX digital camera and processed with the
software system analySIS (Soft Image System). Images were finally processed
using ImageJ (provided by NIH; http://rsb.info.nih.gov/ij/).
Capture of complexes containing GXM and chitin-like structures. The pres-
ence of complexes containing GXM and chitooligomers in supernatants was first
determined by modification of conventional capture enzyme-linked immunosor-
bent assays (ELISAs). Ninety-six-well polystyrene plates were coated with 50 l
of a WGA solution at 1 g/ml and incubated for 1 h at 37°C. After removal of
unbound lectin molecules, the plate was blocked with PBS-BSA. Different dilu-
tions of culture supernatants of C. neoformans after growth in concentrations of
(GlcNAc)3 varying from 0 to 100 g/ml were added to the wells, and the plates
were incubated for 1 h at 37°C. The plates were then washed five times with a
solution of Tris-buffered saline supplemented with 0.1% Tween 20, blocked
again, and incubated with MAb 18B7 for 1 h. The plate was again washed and
incubated with an alkaline phosphatase-conjugated goat anti-mouse IgG1 for
1 h. Reactions were developed after the addition of p-nitrophenyl phosphate
disodium hexahydrate, followed by reading at 405 nm with a microplate reader
(TP-reader; Thermo Plate). Controls included sterile culture medium or incu-
bation of the complete reaction mixture in plates that were not initially coated
with WGA.
The production of complexes containing GXM and chitooligomers in C. neo-
formans cultures was evaluated by affinity chromatography using an agarose
conjugate of WGA (Sigma). The lectin-containing resin (1 ml) was packaged into
a plastic chromatographic column (0.5-cm diameter) and extensively washed with
sterile minimal medium. The column was loaded with a 10-ml sample of 48
h-culture supernatant of C. neoformans. After collection of unbound fractions
and exhaustive washing with minimal medium, fractions that were retained by
the lectin were eluted by passage of 10 ml of a 0.5 M GlcNAc solution through
the column. Ten fractions (1 ml each) were collected and assessed for the
presence of GXM by quantitative ELISA (6).
GXM binding to chitin and chitooligomers. To analyze the affinity of GXM for
-1,4-linked GlcNAc-containing structures, 25 mg of chitin obtained from crab
shells (Sigma) was exhaustively washed with minimal medium and suspended in
0.5 mg/ml GXM solution (1 ml; in minimal medium). This suspension was
incubated for 1 h at 25°C under gentle shaking, followed by removal of unbound
GXM by extensive washing of the insoluble particles with minimal medium. The
insoluble residue was then suspended in minimal medium (1 ml) and transferred
to a plastic chromatographic column (0.5-cm diameter). This material was pack-
aged into the column with minimal medium, and chitin-binding fractions of
GXM were finally eluted with a step gradient of NaCl at concentrations ranging
from 0.1 to 4 M. Three samples (1 ml each) were collected for each salt con-
centration, and the content of GXM in these fractions was determined by
quantitative ELISA (6).
Binding of chitooligomers to GXM fractions was alternatively evaluated by the
analysis of changes in the effective diameter of the polysaccharide after incuba-
tion in the presence of chitooligosaccharides. GXM extracellular fractions ob-
tained by ultrafiltration (27) were dissolved in minimal medium to form 1 mg/ml
solutions and incubated for 1 h at 25°C (control). Alternatively, the GXM
solutions were supplemented with different GlcNAc-containing oligosaccharides
(N,N-diacetyl chitobiose; N,N,N-triacetyl chitotriose; N,N,N,N,N-penta-
acetyl chitopentaose; N,N,N,N,N,N-hexaacetyl chitohexaose) to form 0.01
or 0.1 mg/ml solutions (final oligomer concentration) and then incubated as
described above. Effective diameters of the GXM fractions incubated under
control conditions or in the presence of the chitooligomers were determined by
dynamic light scattering, following the methodology recently described by Frases
and colleagues (14).
India ink counterstaining and morphological analysis. C. neoformans suspen-
sions grown under control conditions or in the presence of the inhibitors of
capsule assembly were placed onto glass slides and mixed with similar volumes of
India ink. The suspensions were covered with glass coverslips and analyzed with
an Axioplan 2 (Zeiss, Germany) microscope. Images were acquired as described
for fluorescence microscopy. Capsule sizes were defined as the distances between
the cell wall and the outer border of the capsule. Capsule measurements were
determined by using the ImageJ software. For sonication experiments, C. neo-
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formans suspensions were placed in microcentrifuge tubes and pulsed 10 times
with an Ultraclear 800 (Unique) sonifier. The capsules were then visualized as
described above.
Scanning electron microscopy. C. neoformans cells obtained after growth un-
der control conditions or in the presence of Nva-FMDP were washed three times
with PBS and fixed in 2.5% glutaraldehyde for 1 h at room temperature. Samples
of fungal cells were serially dehydrated in alcohol, fixed in a critical-point drier
(Samdri-790; Tousimis, Rockville, MD), coated with gold-palladium (Desk-1;
Denton Vacuum, Inc., Cherry Hill, NJ), and analyzed with a JEOL (Tokyo,
Japan) JSM-6400 scanning electron microscope.
Influence of Nva-FMDP on diameter and monosaccharide composition of
capsular fibers. For capsule extraction, C. neoformans cells cultivated under
control conditions or in the presence of Nva-FMDP (10 g/ml; 3  108 cells)
were suspended in dimethyl sulfoxide (DMSO; 15 ml) and incubated for 15 min
with shaking at room temperature (18). Supernatants containing released cap-
sular polysaccharides were collected by centrifugation, and the pellet was again
suspended in 15 ml of DMSO for a second extraction under the same conditions.
Supernatants were combined and extensively dialyzed against water for subse-
quent lyophilization and dry weight determination. GXM fractions obtained by
DMSO extraction were analyzed by dynamic light scattering for effective diam-
eter determination (14) or by gas chromatography-mass spectrometry analysis
after per-O-trimethylsilylation of the products of acidic methanolysis (27).
In vivo analysis and WGA staining. To establish localized pulmonary infec-
tion, male Fischer rats weighing 200 to 250 g were inoculated intratracheally with
1  107 C. neoformans cells, ATCC strain 24067, using an otoscope. This strain
has previously been shown to elicit lung chitinase activity in the rat model (37),
and its staining pattern by WGA was similar to patterns observed for other
cryptococcal strains (see Fig. 9 and reference 32). To establish brain infection,
rats were infected intracisternally with 1  103 C. neoformans cells. In most cases,
rats were sacrificed at 2 weeks, and organs were removed. In some instances,
pulmonary infection was allowed to progress for as long as 1 year prior to organ
harvesting. At the time of sacrifice, organs were removed, fixed in formalin,
embedded in paraffin, and cut into approximately 6-m sections. All animal work
was carried out with the approval of the Animal Use Committee at the Albert
Einstein College of Medicine.
After tissue sections were blocked with PBS-BSA, they were stained with a 5
g/ml solution of the Alexa Fluor 594 conjugate of WGA. To characterize the
staining patterns of C. neoformans in lung and tissue, approximately 70 yeast cells
per slide were counted, and the average from 10 different tissue sections was
determined. Statistical analysis was performed with the chi-square test, using the
Prism for Windows software (version 4.02). The morphological features of
WGA-stained C. neoformans from infected tissues were compared with those
obtained in vitro, which included control or chitinase-treated cells. For chitinase
treatment, PBS-washed yeast cells (106) cultivated in vitro were suspended in 100
l of 0.01 M phosphate buffer (pH 6.0) containing chitinase (100 g/ml; purified
from Streptomyces griseus [Sigma]), followed by incubation at 37°C for 12 h. The
cell suspensions were incubated overnight at 37°C and centrifuged at 4,000 rpm
for cell removal. Controls included cells treated in buffer containing no enzyme.
RESULTS
Binding of GXM to chitin and chitooligomers. Chito-
oligomers were recently described by our group as candidate
molecules that connect the cell wall to capsular GXM (32).
The ability of GXM to bind to -1,4-linked GlcNAc-containing
structures was then explored by incubation of the cryptococcal
polysaccharide with chitin and elution of bound fractions with
increasing concentrations of NaCl. Analysis of eluted fractions
by ELISA revealed one major GXM peak, in addition to sev-
eral minor peaks corresponding to binding of the cryptococcal
polysaccharide to chitin (Fig. 1A). This result suggests that
GXM binding to chitin may occur at different levels of affinity.
The ability of GXM to bind chitin under controlled condi-
tions led us to investigate whether such interaction would nor-
mally occur in C. neoformans under the growth conditions
used. A capture ELISA was then used to detect chitooligomer
(chitotriose)-GXM complexes (Fig. 1B), and the results con-
firmed that GXM-chitotriose complexes formed during fungal
growth (Fig. 1C). Nonspecific binding of the polysaccharide to
the surface of the ELISA plate, which might result in false-
positive results, apparently did not influence serological reac-
tions, as inferred from the results of running the reaction in the
absence of WGA (plates coated with PBS-BSA only) (data not
shown).
Although the efficacy of detection of complexes containing
GXM and chitooligomers in culture fluids was directly influ-
enced by the concentration of the exogenously added oligosac-
charide in the medium, we observed positive ELISA reactions
even when C. neoformans grew without supplementation of
chitooligosaccharides. This observation suggests that a natural
association of chitooligomers with GXM may occur during cryp-
tococcal growth. To isolate these complexes, regular culture
supernatants of C. neoformans were passed through an aga-
rose-WGA column. Bound samples were eluted with 0.5 M
GlcNAc, and the presence of GXM in these fractions was
monitored in ELISAs with a MAb to GXM (MAb 18B7) (6).
The chromatographic profile revealed two peaks of GXM (Fig.
1D), suggesting that WGA captured GlcNAc-containing mol-
ecules from culture supernatants in association with GXM.
Absorbance values related to GXM detection were relatively
low. The results shown in Fig. 1A may suggest that the asso-
ciation of GXM with chitin at pH 5.5 involves noncovalent
bonds, possibly including some electrostatic and hydrophobic
interactions. Therefore, the relatively low absorbance values
probably reflect the fact that GXM-chitooligomer interactions
in culture fluids are likely to be dynamic and transient, and
consequently no quantitative information should be inferred
from these results.
Growth in the presence of chitotriose led to modified
cryptococcal capsules. The association of GXM with chito-
oligomers forming soluble hybrid complexes led us to hypothe-
size that high concentrations of the -1,4-linked GlcNAc
oligosaccharides could affect capsule assembly by interfering with
the incorporation of capsular components by growing cells.
Analysis of India ink-counterstained cells revealed that, after
growth in minimal medium supplemented with (GlcNAc)3
(6.25 g/ml), the capsule of several cells of C. neoformans
became permeable to India ink. The border of the capsule was
apparently well preserved, but the interface of the cell wall
with the capsule was impregnated with India ink, indicating the
abnormal increase of capsular permeability (Fig. 2A and B).
To explore the capsular structure that stained with India ink of
cells grown in the presence of chitooligomers, cryptococci were
stained with MAb 18B7, WGA, and calcofluor for detection,
respectively, of GXM, -1,4-linked chitooligomers, and chitin.
Surprisingly, fluorescence microscopy revealed that yeast cells
with India ink-permeable capsules stained neither with WGA
nor with MAb 18B7 (Fig. 2C and D). In contrast, cryptococcal
cells with a regular profile of India ink counterstaining exhibited
normal reactivity with MAb 18B7. When C. neoformans was cul-
tivated at higher (25 g/ml) concentrations of (GlcNAc)3, a
highly distorted capsular morphology, with longer capsular
projections, was observed (Fig. 2E and F).
Capsule assembly is not required for expression of -1,4-
linked GlcNAc oligomers. The partial sensitivity of the GXM-
chitin linkage to increasing NaCl concentrations (Fig. 1A) is in
line with data from previous studies showing that growth of C.
neoformans in high-salt concentrations resulted in decreased
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expression of capsular polysaccharides (10, 34). We therefore
evaluated whether cultivation of C. neoformans in minimal
medium supplemented with 1 M NaCl would affect expression
of surface chitooligomers. Control cells cultivated in minimal
medium manifested relatively large capsules and patterns of
antibody and lectin binding that were in agreement with pre-
vious observations by our group (32) (Fig. 3A and B). After
cultivation in medium of high osmolarity, most of the yeast
FIG. 1. Association of GXM and chitin-like molecules. (A) Binding of GXM to chitin followed by elution with a step gradient of NaCl resulted
in different GXM peaks. (B) Experimental model used to detect -1,4-linked GlcNAc oligomers in complex with GXM in culture supernatants.
WGA was used to capture chitooligomers. Lectin-coated wells of ELISA microplates were incubated with culture supernatants for further
detection of carbohydrate complexes using a MAb raised to GXM. (C) Chitotriose was added to C. neoformans cultures at different concentrations,
and the chitooligomer-GXM complexes were captured by WGA on ELISA microplates and detected by anti-GXM monoclonal antibody. (D) Two
peaks corresponding to chitotriose-GXM complexes in C. neoformans culture supernatant could be separated by affinity binding to an agarose-
WGA column. AP, alkaline phosphatase.
FIG. 2. Morphological and antibody-reacting features of cryptococcal capsules in yeast cells grown in the presence of (GlcNAc)3. India ink
counterstaining was used to analyze capsule morphology under control conditions (A) or after growth in the presence of the chitooligomer (6.5
g/ml) (B). Scale bar, 10 m. Yeast cells with defective capsules that became permeable to India ink (C; arrows) were not recognized by MAb
18B7 (D). Scale bar, 10 m. Growth of C. neoformans in the presence of a higher (GlcNAc)3 concentration (25 g/ml) results in the formation
of capsules with aberrant morphology that are not permeable to India ink penetration (E). These structures are still recognized by MAb 18B7 (F).
Scale bar, 10 m. Cellular structures stained in blue and green show, respectively, recognition sites of calcofluor and MAb 18B7.
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cells had no visible capsules and were not recognized by the
MAb to GXM (Fig. 3C and D). The minor fraction of the
fungal population that remained fully encapsulated was regu-
larly recognized by the antibody. Growth in high-salt concen-
trations, however, did not affect the expression of surface
-1,4-linked oligomers, indicating that, in agreement with
chromatographic analysis (Fig. 1A), high NaCl concentrations
affect GXM-GlcNAc linkages without interfering with synthe-
sis and surface exposure of chitooligomers in cryptococci.
Interaction with chitooligomers increased diameters of
GXM fibers. The ability of GXM to bind structures related to
chitin and previous studies showing that chitooligomers par-
ticipate in GXM interactions with the cell wall (12, 32) led us
to evaluate whether binding to -1,4-linked GlcNAc-contain-
ing molecules could affect the diameter of GXM fibers. For
this purpose we used the method described by Frases and
coworkers (14), in which the dimensions of GXM fibers were
analyzed by dynamic light scattering. Analysis of the distribu-
tion of polysaccharide molecules as a function of their effective
diameter demonstrated that incubation in the presence of the
-1,4-linked GlcNAc oligomers caused a shift in the distribu-
tion curves to regions of enhanced diameters (Fig. 4). The
increase in the GXM effective diameter was proportional to
the chitooligomer concentration. The only exception was ob-
served when the chitopentamer was used, when the increase in
the effective diameter was apparently not influenced by oligo-
mer concentration. Calculation of the molar ratios of chito-
oligomer and polysaccharide solutions using the values of
GXM molecular mass proposed by McFadden and colleagues
FIG. 3. Analysis of the C. neoformans capsule after growth in minimal
medium (A and B) or in the same medium supplemented with 1 M NaCl
(C and D). (A and B) India ink counterstaining and fluorescence analysis
showing the regular profiles of capsule expression and staining of GXM
and chitooligomers by MAb 18B7 (green fluorescence) and WGA (red
fluorescence), respectively. (C) India ink counterstaining showing that the
vast majority of the yeast cells have no visible capsule. (D) Only the yeast
cells with normal capsules are recognized by the antibody to GXM. Most
cells show the typical profile of staining of -1,4-linked GlcNAc oligomers
by WGA. Scale bar, 10 m.
FIG. 4. Interaction of GXM with chitooligomers of differential lengths affects the effective diameter of the fungal polysaccharide. A shift of the
distribution curves to areas of higher diameter was observed after incubation of GXM in the presence of all -1,4-linked GlcNAc oligosaccharides
in comparison to control systems in the absence of chitooligomers.
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(20) showed that the oligomer-GXM ratios in our model were
in the range of 20 to 1. When these values increased up to 200,
no correlation between oligosaccharide concentration and
polysaccharide diameter was observed (data not shown).
An inhibitor of glucosamine 6-phosphate synthesis affects
cell wall and capsule morphology in C. neoformans. Nva-
FMDP is a dipeptide inhibitor that interferes with early steps
of UDP-GlcNAc synthesis, resulting in defective chitin biosyn-
thesis (21). The fact that growth of C. neoformans in the pres-
ence of chitooligomers affected capsular morphology led us to
evaluate the effects of Nva-FMDP on C. neoformans morphol-
ogy. Yeast growth was barely affected by the inhibitor (data not
shown). In contrast, an overview of the cellular morphology
after fungal cultivation in the presence of Nva-FMDP revealed
several abnormal features (Fig. 5). Four major morphological
alterations were observed for cells growing in the presence of
inhibitor: increased capsule permeability, changed cell wall
architecture, increased cell lysis, and dislocation of cell bodies
from the central position in relation to the capsule. Quantifi-
cation of these morphological cell types showed that as the
number of C. neoformans cells with regular morphology de-
creased, the number of the other types fluctuated (off-center
cell body position, cells with increased capsule permeability,
apparent cell lysis, and cell wall with irregular border) (Fig.
5B). In all cases, the morphological changes induced by the
inhibitor suggested that cell wall and capsular components
were affected. The disturbances in the cell wall morphology
(Fig. 5A) and, especially, the dislocation of the cell body in
relation to the capsule center (Fig. 5C) suggested that connec-
tion of the capsule to the cell wall in C. neoformans had been
affected after fungal growth in the presence of the inhibitor. In
fact, capsules of cells grown with Nva-FMDP were more easily
detached from the cell surface by sonication (Fig. 5D).
Lack of cell wall chitin is correlated with reduced capsular
dimensions in C. neoformans. The cellular activity of Nva-
FMDP in the Cryptococcus model was monitored by staining
fungal cells with calcofluor white, based on the assumption that
lack of calcofluor binding to cell walls implies a deficient chitin
biosynthesis. Therefore, the effects of Nva-FMDP on the
surface architecture of C. neoformans were evaluated by
FIG. 5. Inhibition of glucosamine 6-phosphate synthesis by Nva-FMDP affects the morphology and cell wall-capsule connections in C.
neoformans. (A) Major morphological features of control cells (regular morphology) or of yeast cells cultivated in the presence of Nva-FMDP.
(B) Distribution of the morphological alterations shown in panel A after growth of C. neoformans with Nva-FMDP. (C) Off-center cell bodies
suggesting a possible loose connection between the cell wall and the capsule as induced by the inhibitor. (D) Growth in the presence of increasing
concentrations of Nva-FMDP rendered yeast cells more susceptible to capsule release by sonication. Asterisks denote inhibitor concentrations at
which capsule release by sonication was significantly more efficient than under control conditions (no inhibitor).
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fluorescence microscopy in combination with India ink
counterstaining.
Approximately 40% of the cells grown with 25 g/ml of the
inhibitor had altered chitin expression, as concluded from a
comparison between the numbers of calcofluor-stained yeast
cells grown under control conditions with the number of
stained cells from inhibitor-containing cultures. Several cells
from cultures supplemented with Nva-FMDP were regularly
stained with calcofluor and WGA; these cells showed normal
capsules that reacted with MAb 18B7 (Fig. 6). However, other
cells showed no reactivity with calcofluor. In addition, some
cells were stained for chitin in specific regions of the cell wall
and lacked calcofluor reactivity at other surface sites. In all
cases, negative calcofluor staining was correlated with the ob-
servation of capsular structures with noticeably reduced di-
mensions, as determined by India ink counterstaining in com-
bination with tests of capsular reactivity with MAb 18B7.
Negative calcofluor staining did not result in lack of MAb 18B7
reactivity, indicating that GXM was also associated with the
cell wall of C. neoformans even in cells manifesting reduced
capsules.
The fluorescence profile and related changes in capsule ex-
pression observed after growth of C. neoformans in the pres-
ence of Nva-FMDP led us to evaluate the morphological as-
pects of the capsule by scanning electron microscopy (SEM).
The capsular fibrils of yeast cells exposed to the inhibitor were
noticeably shorter than those in control cells (Fig. 7A, B, D,
and E). In fact, extraction of wall-associated capsular material
with DMSO followed by light-scattering analysis confirmed
FIG. 6. Nva-FMDP interferes with chitin synthesis in C. neoformans
cells. In this assay, calcofluor staining (blue) shows a regular chitin ex-
pression; lack of calcofluor reactivity indicates defective chitin biosynthe-
sis. Staining in red and green indicates, respectively, detection of chito-
oligomers and GXM. Panels A to C show the morphological features of
India ink-counterstained C. neoformans after growth with Nva-FMDP.
Panels D to F show the corresponding fluorescence images. Regions of
the cell surface with defective chitin biosynthesis were associated with
reduced capsule size (arrows). Panels A and D, B and E, and C and F
represent three different experiments prepared under the same conditions
and producing similar results. Scale bar, 1 m.
FIG. 7. Capsule fibrils are affected by growth of C. neoformans in the presence of Nva-FMDP. SEM of control cells at low (A) and high
(B) magnifications show the regular aspects of capsule fibers. These structures were extracted from yeast cells with DMSO, and their effective
diameters were determined by light scattering (C). SEM of fungal cells grown with Nva-FMDP (D and E) showed a reduction in the size
of capsular fibers, which was confirmed by light-scattering analysis of DMSO extracts of capsule material (F). Scale bars, 10 m (A and D)
and 1 m (B and E).
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that the capsular fibers of cells grown in the presence of the
inhibitor (30 g/ml) were shorter than those extracted from
control systems (Fig. 7C and F). Similar results were observed
when C. neoformans cells were cultivated with 10 g/ml Nva-
FMDP (data not shown). These results strongly suggested that
GlcNAc-containing molecules are required for extension of
capsular fibers in C. neoformans, as initially inferred from the
fact that chitooligomers can regulate GXM effective diameter
(Fig. 4).
Capsule composition is influenced by the synthesis of
GlcNAc-containing molecules. The altered dimensions of
capsule fibers observed after cultivation of C. neoformans in
medium supplemented with Nva-FMDP suggested that capsu-
lar structures were modified under these conditions. The
monosaccharide composition of capsular extracts of control
cells and of Nva-FMDP-treated cryptococci was analyzed by
gas chromatography-mass spectrometry (Fig. 8). Mannose, xy-
lose, and glucuronic acid were the main sugar constituents in
control capsular extracts, which also showed trace amounts of
glucose and galactose. Growth in the presence of Nva-FMDP,
however, changed the molar carbohydrate content, with a re-
duced relative amount of glucuronic acid and increased glu-
cose. Therefore, in addition to the morphological alterations
caused by inhibition of GlcNAc synthesis in yeast cells, the
carbohydrate content of C. neoformans capsule was also af-
fected by Nva-FMDP.
Expression of chitooligomers in vivo. Intratracheal inocula-
tion of C. neoformans induces chitinase activity in the lung and
bronchoalveolar lavage fluid of infected rats (37). Since chitin
and chitooligomers participate in the organization of C. neo-
formans cell envelope (1, 2, 32), we investigated the profile of
WGA staining of yeast cells from experimental cryptococcosis
in rats. Sections of lungs and brains from infected animals were
stained with fluorescent WGA and analyzed microscopically.
Two patterns of lectin staining were observed (Fig. 9A). The
first staining profile corresponded to reactivity of the lectin
with restricted areas of the cell surface, which was similar to
the pattern observed in control C. neoformans cells (32). The
second staining profile corresponded to a diffuse pattern of
WGA binding. Diffuse lectin staining is usually observed after
treatment of yeast cells with chitinase, which converts the lo-
calized profile of WGA binding to C. neoformans to a diffuse
pattern of cell wall labeling (32). This effect is attributed to the
enhanced generation of cell wall chitooligosaccharides after
partial enzymatic hydrolysis of chitin (12, 32). Considering that
WGA interacts with -1,4-linked GlcNAc oligomers but not
with chitin in its polymeric form, chitinase treatment generates
an increased number of cellular sites for lectin binding (32).
Therefore, we classified the two visible profiles of C. neofor-
mans lectin staining described above as localized and diffuse
patterns of WGA binding to the cell surface.
In infected lungs of rats, the diffuse pattern observed for
chitinase-treated cells predominated in comparison with the
number of fungal cells presenting the regular, localized profile
of WGA staining (P 	 0.0001) (Fig. 9B). As expected, due to
the much reduced concentration of organ chitinase (15, 28,
37), the opposite pattern was observed in the infected rat brain.
DISCUSSION
Hexosamine metabolism in fungi is crucial for the biosyn-
thesis of several macromolecules, including chitin, chitosan,
and glycoproteins (23). In C. neoformans, synthesis of chitin
and its deacetylated derivative, chitosan, is directly linked with
cell wall assembly and fungal growth (1, 2). At least 14 different
genes are associated with the synthesis of these polymers in
cryptococci, including eight putative chitin synthases, three
putative regulator proteins, and three deacetylases (1, 2). The
relatively high gene redundancy observed for chitin synthases
FIG. 8. Monosaccharide composition of capsular extracts of C.
neoformans after growth under control conditions or in the presence of
Nva-FMDP. Capsular extracts from C. neoformans cultivated in the
presence of the inhibitor showed eightfold less glucuronic acid and a
10-fold increase in the content of glucose.
FIG. 9. WGA reactivity of C. neoformans cells in infected lungs and
brains. (A) Tissue sections were stained with fluorescent WGA and
analyzed microscopically. Results obtained in vivo were compared with
the profiles of lectin reactivity observed in vitro. A limited staining of
specific surface sites (localized pattern; single asterisks) was observed
in untreated control cells compared to the diffuse pattern (double
asterisks) of lectin reactivity in chitinase-treated cells. (B) Quantitative
analysis revealed that the same fluorescence pattern observed for chiti-
nase-treated cells in vitro is abundant in infected lungs, whereas the
lectin binding profile of untreated control cells is more often detected
in infected brains (P 	 0.0001).
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may be responsible for the low susceptibility of C. neoformans
to nikkomycin, an inhibitor of chitin synthesis (17).
Anchoring of the capsule or capsule precursors to the cell
wall is crucial for the pathogenicity of C. neoformans since
capsular components are required for virulence. The interac-
tions between the components of the cell wall and the capsule
responsible for attaching the capsule to the cell wall remain
poorly understood, but various reports suggest that the surface
connections are complex and could involve multiple cell wall
components (29, 30, 32). -1,3-Glucan was the first cell wall
component associated to capsule anchoring. Cryptococcal
cells with disrupted -glucan synthase genes had normal
biosynthesis of capsular material but lacked a surface cap-
sule (30). Mutant cells lacking -1,3-glucan also had modified
cell walls (30), strengthening the notion that the lack of cell
wall glucans could impair buildup of the cell wall and cell
wall-capsule connections.
In a recent report, we demonstrated the existence of chito-
oligomers that form singular round or hook-like connections
between the cell wall and the capsule of C. neoformans (32).
Similar observations with Trichosporon asahii were described
by our group (12). These results suggested that, in addition to
its expected role in the synthesis of cell wall components,
GlcNAc metabolism in fungi could be linked to GXM assem-
bly at the cell surface. In this context, the role played by
chitooligomers and chitin in the process of capsule assembly
was further investigated.
In our model, growth of C. neoformans under conditions that
hampered capsule expression (high salt concentration) re-
sulted in normal expression of chitin oligomers (Fig. 3), sug-
gesting that these structures are constitutively synthesized and
assembled at the cell surface, even in cells lacking visible cap-
sules. Using chromatographic and ELISA-based approaches in
combination with dynamic light scattering (Fig. 1 and 4), we
demonstrated that GXM can interact with chitin and chito-
oligomers. The reactivity of the captured complexes with MAb
18B7 depended on the concentration of the oligomers in the
culture, and, interestingly, positive reactions were observed
even when chitotriose was not added to the medium (data not
shown). In fact, complexes containing GXM and -1,4-linked
GlcNAc-containing structures were isolated from culture su-
pernatants (Fig. 1D), suggesting that such carbohydrate-car-
bohydrate interactions are common events in the cryptococcal
physiology.
The ability of GXM to bind to insoluble chitin and the
detection of complexes containing GXM and chitooligomers
led us to hypothesize that soluble -1,4-linked GlcNAc-con-
taining structures could modify the molecular architecture of
C. neoformans capsular components. Consistent with this hy-
pothesis, yeast cells grown in the presence of chitotriose
showed an altered capsular morphology that was most prom-
inent at the cell wall-capsule interface (Fig. 2). Of particular
interest we note that the permeabilization to India ink pene-
tration observed after growth of C. neoformans in the presence
of chitooligomers resulted in the loss of reactivity of capsular
material with MAb 18B7, suggesting that the epitopes recog-
nized by the antibody are somehow modified in these defective
capsules. In fact, -1,4-linked GlcNAc oligomers altered the
effective diameter of GXM fibrils (Fig. 4), which suggests that
aggregated structures containing larger GXM fibers and
chitooligomers could form compact capsular regions that increase
the permeability to India ink penetration. In addition, poly-
saccharide aggregation mediated by chitooligomers would
likely promote hindrance of O-acetyl epitopes, which are
required for MAb reactivity (16). Chitooligomers could also
modify GXM structure and immunogenicity through the
ionic association of glucuronic acid residues with GlcNAc
units. The amino group on chitin has a pKa of 6.1 (26), im-
plying that chitooligomers would likely be charged at pHs
between 5 and 6, which was the range used for fungal growth
and also in most assays in this study.
To pursue the role of GlcNAc-containing molecules in cap-
sule architecture, we explored the effect of interference with
hexosamine metabolism in C. neoformans using an inhibitor of
the synthesis of glucosamine 6-phosphate, a key step in the
UDP-GlcNAc biosynthetic process (23). Nva-FMDP, the in-
hibitor used in this study, shows a high antifungal efficacy
against C. albicans (21), but its anticryptococcal activity was
limited to alterations in cellular morphology. Budding in the
presence of the inhibitor was not affected (data not shown),
which warranted its use to control the expression of GlcNAc-
containing molecules in viable cryptococcal populations.
Different analyses showed that the interference with the
metabolism of GlcNAc resulted in loosened capsule-cell
wall connections (Fig. 5) and suggested a direct relationship
between a lack of chitin synthesis and reduced capsule size.
Conversely, addition of chitooligomers to the culture medium
at relatively high concentrations resulted in the formation of
aberrant capsules with increased dimensions (Fig. 2E and F).
Staining of fungal cells with MAb 18B7 and observation by
fluorescence microscopy and SEM (Fig. 6 and 7) revealed that
the major capsular component, GXM, was still associated to
the cell wall in Nva-FMDP-treated cells. These analyses, in
association with light-scattering determinations, revealed that
capsular fibers showed reduced effective diameters and, appar-
ently, were less abundant in the cell surface. The reduced
effective diameters of GXM fibrils in cells that had altered
hexosamine metabolism are in agreement with the observation
that chitooligomers may regulate the size of GXM fibers (Fig.
4). Since inhibition of GlcNAc synthesis resulted in reduced
capsule sizes but did not abolish capsule anchoring to the cell
wall, we speculate that part of the capsular material in C.
neoformans cells could be associated to -1,3-glucans and re-
lated molecules at the cell wall (29, 30). The fact that cell wall
components other than chitin-like structures are required for
capsule anchoring was supported by the fact that Saccharomy-
ces cerevisiae yeast cells, which also express WGA-binding
structures, were unable to incorporate exogenous GXM (data
not shown), indicating that chitin-like structures and chito-
oligomers are involved in the external organization of capsular
components rather than in their attachment to the cell wall.
The changes in capsule morphology and physical properties
induced by Nva-FMDP raised the question as to how the cap-
sular composition would be affected after growth in the pres-
ence of the inhibitor. Under this condition the relative con-
centration of glucuronic acid in cell extracts was reduced
eightfold (Fig. 8). We have shown previously that the negative
charges of glucuronic acid are required for ion-mediated GXM
aggregation and capsule enlargement (27). The reduced con-
centration of this acidic sugar could, therefore, account for the
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formation of smaller capsules caused by the inhibitor. Con-
versely, polysaccharide fractions from Nva-FMDP-treated cells
showed an increased content of glucose. The presence of
glucose as a minor component of cryptococcal capsular ex-
tracts has been demonstrated before (13), but presently the
amount of glucose was close to that of xylose, a major GXM
constituent.
In the lungs of mice, but not in whole brain, acidic mamma-
lian chitinase is the sole detectable endogenous chitinase (4).
In rat tissues a comparable acidic chitinase was observed. The
acidic chitinase in rodents is distinct from human chitotriosi-
dase, and the protein could be identified in alveolar macro-
phages of silicotic rats (15), suggesting that in the rat lung this
enzyme could be generated by macrophages. Since chitinase
activity is induced in infected lungs by cryptococcal infections
(37) and not in infected brain tissue (28), it was not surprising
that the profiles of expression of chitooligomers in lung and
brain from rats infected with C. neoformans were different. In
this study, we demonstrate that most of the C. neoformans
yeast cells in infected lungs of rats resemble the pattern of
chitinase-treated cells in vitro while only 21% of the fungal
cells infecting the brain showed the same profile of WGA
staining (Fig. 9). These results suggest that the expression of
chitin-derived molecules in fungi may be modulated by enzy-
matic activities derived from the host, which vary according to
the infected anatomic site. Such variability could be related to
the previously described organ-dependent variation of capsule
thickness in C. neoformans during animal infection (31).
In summary, this study establishes a link between synthesis
and surface distribution of chitin-like structures and the archi-
tecture of the capsule in C. neoformans. As suggested in prior
reports (1, 2), understanding the different steps required for
synthesis of chitin and chitin-like molecules could reveal the
existence of promising antifungal targets. The fact that chitin-
like molecules are both modulated in vivo and associated with
capsule assembly reinforces this idea. In addition, cryptococcal
virulence could be related to the synthesis of chitooligomers,
which makes chitin metabolism and related pathways attractive
areas to be explored within the field of fungal pathogenicity.
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